# The Impact of Collisionality on the Runaway Electron Avalanche during a Tokamak Disruption

Article · Jonathan Arnaud, Christopher McDevitt

- Archive id: arxiv:2401.11291
- Published: 2024-01-20
- Venue: Physics of Plasmas
- DOI: https://doi.org/10.1063/5.0198338
- arXiv: https://arxiv.org/abs/2401.11291
- Citations: 6
- Source URL: https://arxiv.org/abs/2401.11291
- PDF: https://arxiv.org/pdf/2401.11291
- Provenance: arxiv

## Abstract

The exponential growth (avalanching) of runaway electrons (REs) during a tokamak disruption continues to be a large uncertainty in RE modeling. The present work investigates the impact of tokamak geometry on the efficiency of the avalanche mechanism across a broad range of disruption scenarios. It is found that the parameter $ν\_{\*, crit}$ describing the collisionality at the critical energy to run away delineates how toroidal geometry impacts RE formation. In particular, utilizing a reduced but self-consistent description of plasma power balance, it is shown that for a high-density deuterium-dominated plasma, $ν\_{\*, crit}$ is robustly less than one, resulting in a substantial decrease in the efficiency of the RE avalanche compared to predictions from slab geometry. In contrast, for plasmas containing a substantial quantity of neon or argon, $ν\_{\*, crit} \\gtrsim 1$, no reduction of the avalanche is observed due to toroidal geometry. This sharp contrast in the impact of low-versus high-Z material results primarily from the relatively strong radiative cooling from high-Z impurities, enabling the plasma to be radiatively pinned at low temperatures and thus large electric fields, even for modest quantities of high-Z material.

_Abstract reproduced under CC0-1.0 (arXiv descriptive metadata)._

Topics: [Magnetic Confinement Fusion](https://space-kitty.com/topics/magnetic-fusion)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.